The stock of Amyris Incorporated (NASDAQ:AMRS) registered a decrease of 26.34% in short interest. AMRS’s total short interest was 3.09M shares in September as published by FINRA. Its down 26.34% from 4.19 million shares, reported previously. With 3.21 million shares average volume, it will take short sellers 1 days to cover their AMRS’s short positions. The short interest to Amyris Incorporated’s float is 3.54%. About 1.21M shares traded hands. Amyris Inc (NASDAQ:AMRS) has declined 69.66% since February 8, 2016 and is downtrending. It has underperformed by 86.14% the S&P500.
Amyris, Inc. is an integrated industrial biotechnology company. The company has a market cap of $104.14 million. The Firm is engaged in research and development and sales of fuels and farnesene-derived products. It currently has negative earnings. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances , solvents and cleaners, polymers, lubricants, healthcare products and fuels.
The institutional sentiment decreased to 0.39 in 2016 Q2. Its down 1.25, from 1.64 in 2016Q1. The ratio worsened, as 19 funds sold all Amyris Inc shares owned while 9 reduced positions. 2 funds bought stakes while 9 increased positions. They now own 82.40 million shares or 3.93% less from 85.77 million shares in 2016Q1.
Temasek Holdings (Private) Ltd holds 0.24% of its portfolio in Amyris Inc for 69.59 million shares. Kamunting Street Capital Management L.P. owns 91,884 shares or 0.09% of their US portfolio. Moreover, Tpg Group Holdings (Sbs) Advisors Inc. has 0.02% invested in the company for 3.98 million shares. The Georgia-based Concourse Capital Management Llc has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 7,300 shares.
Out of 3 analysts covering Amyris Inc (NASDAQ:AMRS), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Amyris Inc has been the topic of 3 analyst reports since November 10, 2015 according to StockzIntelligence Inc. Cowen & Co maintained the stock on March 10 with “Market Perform” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.